Extended platelet‐rich fibrin

Platelet‐rich fibrin (PRF) has been characterized as a regenerative biomaterial that is fully resorbed within a typical 2–3 week period. Very recently, however, a novel heating process was shown to extend the working properties of PRP/PRF from a standard 2–3 week period toward a duration of 4–6 mont...

Full description

Saved in:
Bibliographic Details
Published in:Periodontology 2000 Vol. 94; no. 1; pp. 114 - 130
Main Authors: Miron, Richard J., Pikos, Michael A., Estrin, Nathan E., Kobayashi‐Fujioka, Masako, Espinoza, Alan Rene, Basma, Hussein, Zhang, Yufeng
Format: Journal Article
Language:English
Published: Denmark 01.02.2024
Subjects:
ISSN:0906-6713, 1600-0757, 1600-0757
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Platelet‐rich fibrin (PRF) has been characterized as a regenerative biomaterial that is fully resorbed within a typical 2–3 week period. Very recently, however, a novel heating process was shown to extend the working properties of PRP/PRF from a standard 2–3 week period toward a duration of 4–6 months. Numerous clinicians have now utilized this extended‐PRF (e‐PRF) membrane as a substitute for collagen barrier membranes in various clinical applications, such as guided tissue/bone regeneration. This review article summarizes the scientific work to date on this novel technology, including its current and future applications in periodontology, implant dentistry, orthopedics and facial aesthetics. A systematic review was conducted investigating key terms including “Bio‐Heat,” “albumin gel,” “albumin‐PRF,” “Alb‐PRF,” “extended‐PRF,” “e‐PRF,” “activated plasma albumin gel,” and “APAG” by searching databases such as MEDLINE, EMBASE and PubMed. Findings from preclinical studies demonstrate that following a simple 10‐min heating process, the transformation of the liquid plasma albumin layer into a gel‐like injectable albumin gel extends the resorption properties to at least 4 months according to ISO standard 10 993 (subcutaneous animal model). Several clinical studies have now demonstrated the use of e‐PRF membranes as a replacement for collagen membranes in GTR/GBR procedures, closing lateral windows in sinus grafting procedures, for extraction site management, and as a stable biological membrane during recession coverage procedures. Furthermore, Alb‐PRF may also be injected as a regenerative biological filler that lasts extended periods with advantages in joint injections, osteoarthritis and in the field of facial aesthetics. This article highlights the marked improvement in the stability and degradation properties of the novel Alb‐PRF/e‐PRF technology with its widespread future potential use as a potential replacement for collagen membranes with indications including extraction site management, GBR procedures, lateral sinus window closure, recession coverage among others, and further highlights its use as a biological regenerative filler for joint injections and facial aesthetics. It is hoped that this review will pioneer future opportunities and research development in the field, leading to further progression toward more natural and less costly biomaterials for use in medicine and dentistry.
AbstractList Platelet‐rich fibrin (PRF) has been characterized as a regenerative biomaterial that is fully resorbed within a typical 2–3 week period. Very recently, however, a novel heating process was shown to extend the working properties of PRP/PRF from a standard 2–3 week period toward a duration of 4–6 months. Numerous clinicians have now utilized this extended‐PRF (e‐PRF) membrane as a substitute for collagen barrier membranes in various clinical applications, such as guided tissue/bone regeneration. This review article summarizes the scientific work to date on this novel technology, including its current and future applications in periodontology, implant dentistry, orthopedics and facial aesthetics. A systematic review was conducted investigating key terms including “Bio‐Heat,” “albumin gel,” “albumin‐PRF,” “Alb‐PRF,” “extended‐PRF,” “e‐PRF,” “activated plasma albumin gel,” and “APAG” by searching databases such as MEDLINE, EMBASE and PubMed. Findings from preclinical studies demonstrate that following a simple 10‐min heating process, the transformation of the liquid plasma albumin layer into a gel‐like injectable albumin gel extends the resorption properties to at least 4 months according to ISO standard 10 993 (subcutaneous animal model). Several clinical studies have now demonstrated the use of e‐PRF membranes as a replacement for collagen membranes in GTR/GBR procedures, closing lateral windows in sinus grafting procedures, for extraction site management, and as a stable biological membrane during recession coverage procedures. Furthermore, Alb‐PRF may also be injected as a regenerative biological filler that lasts extended periods with advantages in joint injections, osteoarthritis and in the field of facial aesthetics. This article highlights the marked improvement in the stability and degradation properties of the novel Alb‐PRF/e‐PRF technology with its widespread future potential use as a potential replacement for collagen membranes with indications including extraction site management, GBR procedures, lateral sinus window closure, recession coverage among others, and further highlights its use as a biological regenerative filler for joint injections and facial aesthetics. It is hoped that this review will pioneer future opportunities and research development in the field, leading to further progression toward more natural and less costly biomaterials for use in medicine and dentistry.
Platelet-rich fibrin (PRF) has been characterized as a regenerative biomaterial that is fully resorbed within a typical 2-3 week period. Very recently, however, a novel heating process was shown to extend the working properties of PRP/PRF from a standard 2-3 week period toward a duration of 4-6 months. Numerous clinicians have now utilized this extended-PRF (e-PRF) membrane as a substitute for collagen barrier membranes in various clinical applications, such as guided tissue/bone regeneration. This review article summarizes the scientific work to date on this novel technology, including its current and future applications in periodontology, implant dentistry, orthopedics and facial aesthetics. A systematic review was conducted investigating key terms including "Bio-Heat," "albumin gel," "albumin-PRF," "Alb-PRF," "extended-PRF," "e-PRF," "activated plasma albumin gel," and "APAG" by searching databases such as MEDLINE, EMBASE and PubMed. Findings from preclinical studies demonstrate that following a simple 10-min heating process, the transformation of the liquid plasma albumin layer into a gel-like injectable albumin gel extends the resorption properties to at least 4 months according to ISO standard 10 993 (subcutaneous animal model). Several clinical studies have now demonstrated the use of e-PRF membranes as a replacement for collagen membranes in GTR/GBR procedures, closing lateral windows in sinus grafting procedures, for extraction site management, and as a stable biological membrane during recession coverage procedures. Furthermore, Alb-PRF may also be injected as a regenerative biological filler that lasts extended periods with advantages in joint injections, osteoarthritis and in the field of facial aesthetics. This article highlights the marked improvement in the stability and degradation properties of the novel Alb-PRF/e-PRF technology with its widespread future potential use as a potential replacement for collagen membranes with indications including extraction site management, GBR procedures, lateral sinus window closure, recession coverage among others, and further highlights its use as a biological regenerative filler for joint injections and facial aesthetics. It is hoped that this review will pioneer future opportunities and research development in the field, leading to further progression toward more natural and less costly biomaterials for use in medicine and dentistry.Platelet-rich fibrin (PRF) has been characterized as a regenerative biomaterial that is fully resorbed within a typical 2-3 week period. Very recently, however, a novel heating process was shown to extend the working properties of PRP/PRF from a standard 2-3 week period toward a duration of 4-6 months. Numerous clinicians have now utilized this extended-PRF (e-PRF) membrane as a substitute for collagen barrier membranes in various clinical applications, such as guided tissue/bone regeneration. This review article summarizes the scientific work to date on this novel technology, including its current and future applications in periodontology, implant dentistry, orthopedics and facial aesthetics. A systematic review was conducted investigating key terms including "Bio-Heat," "albumin gel," "albumin-PRF," "Alb-PRF," "extended-PRF," "e-PRF," "activated plasma albumin gel," and "APAG" by searching databases such as MEDLINE, EMBASE and PubMed. Findings from preclinical studies demonstrate that following a simple 10-min heating process, the transformation of the liquid plasma albumin layer into a gel-like injectable albumin gel extends the resorption properties to at least 4 months according to ISO standard 10 993 (subcutaneous animal model). Several clinical studies have now demonstrated the use of e-PRF membranes as a replacement for collagen membranes in GTR/GBR procedures, closing lateral windows in sinus grafting procedures, for extraction site management, and as a stable biological membrane during recession coverage procedures. Furthermore, Alb-PRF may also be injected as a regenerative biological filler that lasts extended periods with advantages in joint injections, osteoarthritis and in the field of facial aesthetics. This article highlights the marked improvement in the stability and degradation properties of the novel Alb-PRF/e-PRF technology with its widespread future potential use as a potential replacement for collagen membranes with indications including extraction site management, GBR procedures, lateral sinus window closure, recession coverage among others, and further highlights its use as a biological regenerative filler for joint injections and facial aesthetics. It is hoped that this review will pioneer future opportunities and research development in the field, leading to further progression toward more natural and less costly biomaterials for use in medicine and dentistry.
Author Zhang, Yufeng
Miron, Richard J.
Kobayashi‐Fujioka, Masako
Espinoza, Alan Rene
Basma, Hussein
Pikos, Michael A.
Estrin, Nathan E.
Author_xml – sequence: 1
  givenname: Richard J.
  surname: Miron
  fullname: Miron, Richard J.
  email: richard.miron@zmk.unibe.ch, rick@themironlab.com
  organization: University of Bern
– sequence: 2
  givenname: Michael A.
  surname: Pikos
  fullname: Pikos, Michael A.
  organization: Pikos Institute
– sequence: 3
  givenname: Nathan E.
  surname: Estrin
  fullname: Estrin, Nathan E.
  organization: Advanced PRF Education
– sequence: 4
  givenname: Masako
  surname: Kobayashi‐Fujioka
  fullname: Kobayashi‐Fujioka, Masako
  organization: The Nippon Dental University
– sequence: 5
  givenname: Alan Rene
  surname: Espinoza
  fullname: Espinoza, Alan Rene
  organization: Pikos Institute
– sequence: 6
  givenname: Hussein
  surname: Basma
  fullname: Basma, Hussein
  organization: Pikos Institute
– sequence: 7
  givenname: Yufeng
  orcidid: 0000-0001-8702-5291
  surname: Zhang
  fullname: Zhang, Yufeng
  organization: University of Wuhan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37986559$$D View this record in MEDLINE/PubMed
BookMark eNp1kMtOwzAQRS1URB-w4AegS1ikteM4jpeolIdUCYRgbTn2WBilSbBTQXd8At_Il2Bo2SCYzWzOPZq5Q9SrmxoQOiR4QuJMW28mJGWU76AByTFOMGe8hwZY4DzJOaF9NAzhCWPCBWV7qE-5KHLGxAAdz187qA2YcVupDiroPt7evdOPY-tK7-p9tGtVFeBgu0fo4WJ-P7tKFjeX17OzRaJpjnliKfDMaNCCloCJ0UYxmwsijBYlWKZNPK9QhKnCEJzpnGWZAat0ajlwqukInWy8rW-eVxA6uXRBQ1WpGppVkGkh0jQKMY7o0RZdlUswsvVuqfxa_jwVgekG0L4JwYOV2nWqc03deeUqSbD8qi0GjfyuLSZOfyV-pH-xW_uLq2D9Pyhv7843iU9-f3w4
CitedBy_id crossref_primary_10_3390_jfb16100357
crossref_primary_10_1007_s00784_024_06119_x
crossref_primary_10_1186_s12903_025_06115_x
crossref_primary_10_24911_ejmcr_173_1701008366
crossref_primary_10_1002_adfm_202415185
crossref_primary_10_1111_prd_12625
crossref_primary_10_1080_09537104_2024_2414792
crossref_primary_10_1111_prd_12626
crossref_primary_10_1016_j_otc_2025_02_004
crossref_primary_10_1111_prd_12582
crossref_primary_10_1111_jre_70013
crossref_primary_10_1186_s12903_024_05223_4
crossref_primary_10_63618_omd_isj_v3_n3_86
crossref_primary_10_1002_cap_10330
crossref_primary_10_4103_jioh_jioh_259_24
crossref_primary_10_1177_23800844251325532
crossref_primary_10_3390_dj13040179
crossref_primary_10_1111_prd_12635
crossref_primary_10_1177_22808000241299588
crossref_primary_10_3390_ijms26189120
crossref_primary_10_1111_jre_13413
crossref_primary_10_4103_JCDE_JCDE_245_25
crossref_primary_10_1111_prd_12555
crossref_primary_10_62347_QJPT4439
crossref_primary_10_3390_molecules30163415
crossref_primary_10_1111_cid_13427
crossref_primary_10_1007_s00784_024_05617_2
crossref_primary_10_63580_iti_fi_45740
crossref_primary_10_1007_s11033_024_09890_y
crossref_primary_10_1186_s13256_024_04458_7
Cites_doi 10.1016/j.actbio.2018.05.021
10.1080/09537104.2020.1717455
10.3390/ijms222111333
10.1007/s00784-017-2063-9
10.1038/s41598-018-30454-1
10.1016/j.tripleo.2006.10.009
10.1902/jop.2016.160443
10.1111/prd.12521
10.1089/ten.teb.2016.0233
10.3390/antiox9060560
10.1007/s00784-019-03147-w
10.1007/s00784-017-2161-8
10.3389/fimmu.2021.636427
10.1007/s00784-018-2673-x
10.3390/ma13163466
10.1007/s00784-017-2133-z
10.1007/s00784-020-03303-7
10.1177/0363546509349921
10.1002/jbm.b.33262
10.20883/jms.2017.225
10.1007/s00784-016-1719-1
10.4103/GFSC.GFSC_21_18
10.1080/09537104.2020.1775188
10.1111/jocd.12876
ContentType Journal Article
Copyright 2023 The Authors. published by John Wiley & Sons Ltd.
2023 The Authors. Periodontology 2000 published by John Wiley & Sons Ltd.
Copyright_xml – notice: 2023 The Authors. published by John Wiley & Sons Ltd.
– notice: 2023 The Authors. Periodontology 2000 published by John Wiley & Sons Ltd.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/prd.12537
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Dentistry
EISSN 1600-0757
EndPage 130
ExternalDocumentID 37986559
10_1111_prd_12537
PRD12537
Genre reviewArticle
Systematic Review
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
24P
29O
31~
33P
34H
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHQN
AAIPD
AAKAS
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
CWXXS
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.T
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
UMD
VVN
W8V
W99
WBKPD
WBNRW
WIH
WIJ
WIK
WOHZO
WPGGZ
WQJ
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
AIQQE
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3607-f3e74dcec93be01dcda5f6919dc9bef5cd2538a15a8d104c6544defac2f7e73c3
IEDL.DBID 24P
ISICitedReferencesCount 31
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001104712900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0906-6713
1600-0757
IngestDate Sun Nov 09 11:34:48 EST 2025
Mon Jul 21 06:04:33 EDT 2025
Sat Nov 29 02:17:34 EST 2025
Tue Nov 18 21:04:16 EST 2025
Sun Jul 06 04:45:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords albumin‐gel
platelet‐rich fibrin
bio‐PRF
bio‐heat
bio‐filler
Language English
License Attribution
2023 The Authors. Periodontology 2000 published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3607-f3e74dcec93be01dcda5f6919dc9bef5cd2538a15a8d104c6544defac2f7e73c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0001-8702-5291
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fprd.12537
PMID 37986559
PQID 2892269100
PQPubID 23479
PageCount 17
ParticipantIDs proquest_miscellaneous_2892269100
pubmed_primary_37986559
crossref_citationtrail_10_1111_prd_12537
crossref_primary_10_1111_prd_12537
wiley_primary_10_1111_prd_12537_PRD12537
PublicationCentury 2000
PublicationDate February 2024
2024-02-00
2024-Feb
20240201
PublicationDateYYYYMMDD 2024-02-01
PublicationDate_xml – month: 02
  year: 2024
  text: February 2024
PublicationDecade 2020
PublicationPlace Denmark
PublicationPlace_xml – name: Denmark
PublicationTitle Periodontology 2000
PublicationTitleAlternate Periodontol 2000
PublicationYear 2024
References 2007; 103
2017; 86
2021; 22
2015; 103
2017; 88
2017; 21
2017; 23
2024; 94
2019; 18
2020; 36
2020; 13
2020; 12
2018; 23
2018; 22
2018; 8
2021; 32
2021; 12
2018; 1
2020
2021; 19
2020; 9
2016; 20
2018
2020; 24
2018; 75
2009; 37
e_1_2_8_28_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
Davies C (e_1_2_8_29_1) 2020
Sun JL (e_1_2_8_18_1) 2020; 36
e_1_2_8_10_1
Garg A (e_1_2_8_12_1) 2018
e_1_2_8_11_1
Shirakata Y (e_1_2_8_19_1) 2021; 19
References_xml – volume: 9
  issue: 6
  year: 2020
  article-title: Platelet‐rich fibrin can neutralize hydrogen peroxide‐induced cell death in gingival fibroblasts
  publication-title: Antioxidants (Basel, Switzerland)
– volume: 32
  start-page: 74
  issue: 1
  year: 2021
  end-page: 81
  article-title: Biological characterization of an injectable platelet‐rich fibrin mixture consisting of autologous albumin gel and liquid platelet‐rich fibrin (Alb‐PRF)
  publication-title: Platelets
– volume: 19
  start-page: 537
  issue: 1
  year: 2021
  end-page: 546
  article-title: Histological evaluation of gingival and Intrabony periodontal defects treated with platelet‐rich fibrin using different protocols: a canine study
  publication-title: Oral Health Prev Dent
– volume: 32
  start-page: 542
  issue: 4
  year: 2021
  end-page: 554
  article-title: In vivo evaluation of the biocompatibility and biodegradation of a new denatured plasma membrane combined with liquid PRF (Alb‐PRF)
  publication-title: Platelets
– volume: 21
  start-page: 2619
  year: 2017
  end-page: 2627
  article-title: Injectable platelet rich fibrin (i‐PRF): opportunities in regenerative dentistry?
  publication-title: Clin Oral Investig
– volume: 21
  start-page: 1913
  issue: 6
  year: 2017
  end-page: 1927
  article-title: Use of platelet‐rich fibrin in regenerative dentistry: a systematic review
  publication-title: Clin Oral Investig
– volume: 12
  start-page: 4373
  year: 2020
  end-page: 4383
  article-title: Improved growth factor delivery and cellular activity using concentrated platelet‐rich fibrin (C‐PRF) when compared with traditional injectable (i‐PRF) protocols
  publication-title: Clin Oral Investig
– volume: 88
  start-page: 112
  issue: 1
  year: 2017
  end-page: 121
  article-title: Optimized platelet‐rich fibrin with the low‐speed concept: growth factor release, biocompatibility, and cellular response
  publication-title: J Periodontol
– volume: 103
  start-page: 305
  issue: 3
  year: 2007
  end-page: 306
  article-title: PRP, cPRP, PRF, PRG, PRGF, FC… how to find your way in the jungle of platelet concentrates?
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 23
  start-page: 83
  issue: 1
  year: 2017
  end-page: 99
  article-title: Platelet‐rich fibrin and soft tissue wound healing: a systematic review
  publication-title: Tissue Eng Part B Rev
– volume: 22
  issue: 21
  year: 2021
  article-title: Platelet‐rich fibrin decreases the inflammatory response of mesenchymal cells
  publication-title: Int J Mol Sci
– volume: 86
  start-page: 173
  issue: 2
  year: 2017
  end-page: 176
  article-title: Revitalization of facial skin based on preparations of patient own blood
  publication-title: J Med Sci
– volume: 24
  start-page: 2819
  issue: 8
  year: 2020
  end-page: 2828
  article-title: A novel method for harvesting concentrated platelet‐rich fibrin (C‐PRF) with a 10‐fold increase in platelet and leukocyte yields
  publication-title: Clin Oral Investig
– volume: 94
  start-page: 79
  year: 2024
  end-page: 91
  article-title: Optimization of platelet‐rich fibrin
  publication-title: Periodontol 2000
– start-page: 188
  year: 2018
– volume: 18
  start-page: 1271
  year: 2019
  end-page: 1279
  article-title: Assessment of the efficacy and safety of platelet poor plasma gel as autologous dermal filler for facial rejuvenation
  publication-title: J Cosmet Dermatol
– volume: 75
  start-page: 35
  year: 2018
  end-page: 51
  article-title: Autologous liquid platelet rich fibrin: a novel drug delivery system
  publication-title: Acta Biomater
– volume: 22
  start-page: 847
  issue: 2
  year: 2018
  end-page: 857
  article-title: The role of macrophage polarization on fibroblast behavior—an in vitro investigation on titanium surfaces
  publication-title: Clin Oral Investig
– volume: 37
  start-page: 2259
  issue: 11
  year: 2009
  end-page: 2272
  article-title: Platelet‐rich plasma: from basic science to clinical applications
  publication-title: Am J Sports Med
– volume: 23
  start-page: 2179
  year: 2018
  end-page: 2185
  article-title: The effect of age, gender, and time between blood draw and start of centrifugation on the size outcomes of platelet‐rich fibrin (PRF) membranes
  publication-title: Clin Oral Investig
– year: 2020
– volume: 13
  issue: 16
  year: 2020
  article-title: Liquid platelet‐rich fibrin and heat‐coagulated albumin gel: bioassays for TGF‐β activity
  publication-title: Materials (Basel)
– volume: 36
  start-page: 210
  issue: 3
  year: 2020
  end-page: 218
  article-title: Clinical effects of concentrated growth factor combined with plasma albumin gel in treating facial depressed scar
  publication-title: Zhonghua Shao Shang Za Zhi
– volume: 103
  start-page: 825
  issue: 4
  year: 2015
  end-page: 831
  article-title: The heat‐compression technique for the conversion of platelet‐rich fibrin preparation to a barrier membrane with a reduced rate of biodegradation
  publication-title: J Biomed Mater Res B Appl Biomater
– volume: 20
  start-page: 2353
  issue: 9
  year: 2016
  end-page: 2360
  article-title: Comparative release of growth factors from PRP, PRF, and advanced‐PRF
  publication-title: Clin Oral Investig
– volume: 1
  start-page: 64
  issue: 2
  year: 2018
  article-title: Characterization of a new membrane from concentrated growth factors associated with denaturized albumin (Alb‐CGF) for clinical applications: a preliminary study
  publication-title: Int J Growth Factors Stem Cells Dent
– volume: 8
  start-page: 11896
  issue: 1
  year: 2018
  article-title: Feasibility of autologous plasma gel for tonsil‐derived stem cell therapeutics in hypoparathyroidism
  publication-title: Sci Rep
– volume: 12
  year: 2021
  article-title: Liquid PRF reduces the inflammatory response and osteoclastogenesis in murine macrophages
  publication-title: Front Immunol
– ident: e_1_2_8_26_1
  doi: 10.1016/j.actbio.2018.05.021
– ident: e_1_2_8_6_1
  doi: 10.1080/09537104.2020.1717455
– volume: 36
  start-page: 210
  issue: 3
  year: 2020
  ident: e_1_2_8_18_1
  article-title: Clinical effects of concentrated growth factor combined with plasma albumin gel in treating facial depressed scar
  publication-title: Zhonghua Shao Shang Za Zhi
– ident: e_1_2_8_16_1
  doi: 10.3390/ijms222111333
– start-page: 188
  volume-title: Autologous platelet concentrates
  year: 2018
  ident: e_1_2_8_12_1
– ident: e_1_2_8_23_1
  doi: 10.1007/s00784-017-2063-9
– ident: e_1_2_8_9_1
  doi: 10.1038/s41598-018-30454-1
– ident: e_1_2_8_27_1
  doi: 10.1016/j.tripleo.2006.10.009
– volume-title: Platelet Rich Fibrin in Facial Esthetics
  year: 2020
  ident: e_1_2_8_29_1
– ident: e_1_2_8_4_1
  doi: 10.1902/jop.2016.160443
– ident: e_1_2_8_22_1
  doi: 10.1111/prd.12521
– ident: e_1_2_8_2_1
  doi: 10.1089/ten.teb.2016.0233
– ident: e_1_2_8_21_1
  doi: 10.3390/antiox9060560
– volume: 19
  start-page: 537
  issue: 1
  year: 2021
  ident: e_1_2_8_19_1
  article-title: Histological evaluation of gingival and Intrabony periodontal defects treated with platelet‐rich fibrin using different protocols: a canine study
  publication-title: Oral Health Prev Dent
– ident: e_1_2_8_13_1
  doi: 10.1007/s00784-019-03147-w
– ident: e_1_2_8_24_1
  doi: 10.1007/s00784-017-2161-8
– ident: e_1_2_8_17_1
  doi: 10.3389/fimmu.2021.636427
– ident: e_1_2_8_25_1
  doi: 10.1007/s00784-018-2673-x
– ident: e_1_2_8_15_1
  doi: 10.3390/ma13163466
– ident: e_1_2_8_3_1
  doi: 10.1007/s00784-017-2133-z
– ident: e_1_2_8_14_1
  doi: 10.1007/s00784-020-03303-7
– ident: e_1_2_8_28_1
  doi: 10.1177/0363546509349921
– ident: e_1_2_8_8_1
  doi: 10.1002/jbm.b.33262
– ident: e_1_2_8_20_1
  doi: 10.20883/jms.2017.225
– ident: e_1_2_8_5_1
  doi: 10.1007/s00784-016-1719-1
– ident: e_1_2_8_11_1
  doi: 10.4103/GFSC.GFSC_21_18
– ident: e_1_2_8_7_1
  doi: 10.1080/09537104.2020.1775188
– ident: e_1_2_8_10_1
  doi: 10.1111/jocd.12876
SSID ssj0017935
Score 2.5365489
SecondaryResourceType review_article
Snippet Platelet‐rich fibrin (PRF) has been characterized as a regenerative biomaterial that is fully resorbed within a typical 2–3 week period. Very recently,...
Platelet-rich fibrin (PRF) has been characterized as a regenerative biomaterial that is fully resorbed within a typical 2-3 week period. Very recently,...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 114
SubjectTerms albumin‐gel
Animals
Biocompatible Materials
bio‐filler
bio‐heat
bio‐PRF
Bone Regeneration - physiology
Guided Tissue Regeneration, Periodontal - methods
Humans
Membranes, Artificial
Platelet-Rich Fibrin
Title Extended platelet‐rich fibrin
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fprd.12537
https://www.ncbi.nlm.nih.gov/pubmed/37986559
https://www.proquest.com/docview/2892269100
Volume 94
WOSCitedRecordID wos001104712900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Journals
  customDbUrl:
  eissn: 1600-0757
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017935
  issn: 0906-6713
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEB5qK-jF96M-ahUPXhb2lc0GT2JbPJRSioXelmweeCjb0lrP_gR_o7_ESfaBooLgZdlDEiaZmcw3ycwE4FpJxpWkxCFCcQc10XVSHpo0Lmmqi6OJSG0R1z4dDOLJhA1rcFvmwuT1IaoDN6MZdr82Cs7T5SclNwUS0ToHdA0anhdQI9J-OKyuEFDwbPwiQ5c5QlesKCtkwniqrl-N0TeE-RWwWovT2_4XrTuwVQDN9l0uGbtQU9kebHRMcJB5320fLrrF-Xd7PkXAifx7f33DXfGprU0aQHYA41738f7BKZ5LcEQQudTRgaKhFEqwIFWuJ4XkREfMY1KwVGkiJFIQc4_wWKITJiIShlJpLnxNFQ1EcAj1bJapY2gjz5j2g4j4Es0_87jQSA7lwiU4khZNuCnXLRFFLXHzpMU0KX0KnHFiZ9yEq6rpPC-g8VOjy3LxExRvc2fBMzVbLRP0BxEgIqZxm3CUc6UaBnlu0moZUmMX__fxk-GoY39O_t70FDZ9BDB5hPYZ1J8XK3UO6-IF2bRoWVnDL53ELWh0Rr1x_wMOaNlf
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEB5qK9SL70d9tYoHLwu7zWbTgBexLRVrKaWF3pY0DzyUbanWsz_B3-gvcbIvLCoI3vaQHSaZmcw3ycwE4EorLrRi1KFSCwct0XUmwrdlXMp2F0cXMYmbuHZZr9cYj3m_ADdZLUzSHyI_cLOWEe_X1sDtgfQXK7cdEtE9E7YGJR_ViBah1By0R938FgF1L05h5Bg1BxiNpZ2FbCZP_vOqP_oGMlcxa-x02lv_Y3cbNlOwWbtNtGMHCjrahXLTJgjZN972oNpKz8Br8ymCTpThx9s77oxPNWNLAaJ9GLVbw7uOkz6Z4EgSuMwxRDNfSS05mWjXU1IJagLucSX5RBsqFXLQEB4VDYWBmAyo7ytthKwbphmR5ACK0SzSR1BDuXFTJwGtK4QA3BPSIDtMSJciJSMrcJ0tXCjTfuL2WYtpmMUVOOMwnnEFLvOh86SJxk-DLrLVD1HF7b2FiPRs-RxiTIggEXGNW4HDRCw5GcK4La3lyE28-r_TD_uDZvxx_PehVSh3ho_dsHvfeziBjToCmiRj-xSKL4ulPoN1-YoiW5ynqvcJCgPcVA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEB5qFfXi-1FfXcWDl4XtZrNpwIvYFsVSFlHobcnmgYeyLdV69if4G_0lTvaFRQXB2x6yYZKZyXyTTL4AnGvFhVaMulRq4aInem4iAnuNS1l2cQwRSUbi2meDQXs45FENLsu7MDk_RLXhZj0jW6-tg-uJMl-83DIkYngmbAEWA4prrOV1DqLqDAEtLytg5Jgzh5iLFbxCto6n-nU-Gn2DmPOINQs5vfX_CbsBawXUdK5y29iEmk63YKVjy4PsC2_b0OwWO-DOZISQEzX48faO6-KTY-xFgHQHHnvdh-sbt3gwwZUk9JhriGaBklpykmivpaQS1IS8xZXkiTZUKpSgLVpUtBWmYTKkQaC0EdI3TDMiyS7U03Gq98FBrXHjk5D6CgEAbwlpUBwmpEexJyMbcFFOXCwLNnH7qMUoLrMKHHGcjbgBZ1XTSU6h8VOj03L2YzRwe2ohUj2ePceYESJERFTjNWAvV0vVDWHcXqzlKE02-7_3H0f3nezj4O9Nm7AcdXpx_3ZwdwirPqKZvFz7COov05k-hiX5ihqbnmR29wnboto9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extended+platelet-rich+fibrin&rft.jtitle=Periodontology+2000&rft.au=Miron%2C+Richard+J&rft.au=Pikos%2C+Michael+A&rft.au=Estrin%2C+Nathan+E&rft.au=Kobayashi-Fujioka%2C+Masako&rft.date=2024-02-01&rft.issn=1600-0757&rft.eissn=1600-0757&rft.volume=94&rft.issue=1&rft.spage=114&rft_id=info:doi/10.1111%2Fprd.12537&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0906-6713&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0906-6713&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0906-6713&client=summon